That position, taken together with this latest deal, points to a possible future for the company as a royalty management outfit – akin to that of its would-be acquirer, the New York-based Paul Royalty Fund – but this is not the only path it intends to pursue

If the option is exercised, New York-based Forest will make payments of up to $430 million, depending upon the achievement of development and commercial milestones, plus royalties, and will carry forward the development and commercialization of TRV027

N30 also is remarkable for raising funding entirely from "New York-based private capital," including Deerfield Capital Management LLC and its founder, Arnold Snider

York-based Pfizer Inc

New York-based Royalty Pharma, which has made a hostile bid of $7.3 billion for Elan, has explicitly alluded to this in an investor presentation: "If Elan management was raising a fund to go out and buy unknown companies and products around the globe, would you invest $4.4 billion with them

York-based Pfizer Inc

New York-based Royalty Pharma, which has made a hostile bid of $7.3 billion for Elan, has explicitly alluded to this in an investor presentation: "If Elan management was raising a fund to go out and buy unknown companies and products around the globe, would you invest $4.4 billion with them

Amgen indicated that demand trends have not changed," wrote analyst Eric Schmidt, of New York-based Cowen and Co., in a research note, "but that much of the sequential decline in sales was due to late 2012 buy-ins by secondary customers ahead of Q1 price increases

plc, of Dublin, Ireland, said its board has determined that New York-based Royalty Pharma's offer to acquire the company for $11.25 or less per share substantially undervalues the company

plc, of Dublin, Ireland, said its board has determined that New York-based Royalty Pharma's offer to acquire the company for $11.25 or less per share substantially undervalues the company

The venture capital environment in biotech is severely stressed," said Jonathan Leff, partner at New York-based Deerfield Management and chairman of the Deerfield Institute, who serves on the boards for both BIO and the NVCA and has attended the convention for most of his 17 years as a venture capitalist

New York-based BMS will hold worldwide rights to whatever products emerge from the alliance...Its other partners include New York-based Pfizer Inc

New York-based BMS will hold worldwide rights to whatever products emerge from the alliance...Its other partners include New York-based Pfizer Inc

In 2007, dalbavancin, which was then owned by New York-based Pfizer Inc. (acquired in the Vicuron Pharmaceuticals Inc. buyout of 2005), got snagged in the FDA's shifting guidelines on antibiotic development, earning a rejection despite hitting its endpoint in an 800-patient noninferiority trial in skin infections

The Pfizer deal goes a step further than the Amgen agreement, which involved the development of a nanotechnology-based therapeutic for solid tumors, with up-front and development milestones totaling $46.5 million plus $134 million in potential regulatory and sales milestones for the first therapeutic indication. (See BioWorld Today, Jan. 9, 2013.) New York-based Pfizer took an exclusive option to develop and commercialize multiple Accurins following collaborative preclinical research between

Tetragenetics Inc., of Cambridge, Mass., said it inked a deal with an option for an exclusive license with New York-based Pfizer Inc

Based on PFS, we know that there is no way this drug will get to approval in any country in the world," said Jonathan Lewis, CEO of New York-based Ziopharm in a conference call

New York-based Bristol-Myers Squibb Co.'s CTLA-4 blocker Yervoy (ipilimumab), approved in 2011, garnered a median OS of 10 months vs

The New York-based company has more than 20 programs across the network of labs that are located in San Diego, San Francisco, Boston and New York